IMCD NV/ NL0010801007 /
10/11/2024 5:39:33 PM | Chg. +1.00 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
152.90EUR | +0.66% | 78,872 Turnover: 12.04 mill. |
150.10Bid Size: 1 | 154.50Ask Size: 6 | 8.7 bill.EUR | 1.47% | 29.81 |
GlobeNewswire
3/2/2022
Hillstream BioPharma R&D Day Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Ac...
GlobeNewswire
2/16/2022
Hillstream BioPharma Receives Orphan Drug Designation for HSB-1216 for the Treatment of Uveal Melano...
GlobeNewswire
3/18/2020
Ergomed Announces Provision of Clinical Research Services for COVID-19 Clinical Study
GlobeNewswire
1/13/2020
EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANT® ...
GlobeNewswire
2/28/2019
Adhesives - Global Market Analysis, Trends and Forecasts 2019: Outsourcing of Manufacturing Activity...
GlobeNewswire
11/16/2018
Asia Pacific Biopharma Excipients (Polyols, Solubilizers & Surfactants/Emulsifiers, Carbohydrates, S...
GlobeNewswire
9/26/2018
IMCD completes acquisition of European speciality chemicals distributor Velox
GlobeNewswire
8/1/2018
IMCD completes acquisition of US specialty chemicals distributor E.T. Horn Company
GlobeNewswire
3/5/2018
Nutraceutical Excipients Market Poised to Register 7.3% CAGR through 2026, globally - Future Market ...
GlobeNewswire
3/2/2018
IMCD to nominate Management Board and Supervisory Board members for (re)appointment
GlobeNewswire
2/8/2018
Adhesives Markets 2016-2024 by Volume & Value - Global Strategic Business Report 2017